There are 2949 resources available
Welcome and introductions
Presenter: Eva Ciruelos
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
HER past: Looking back on two decades of HER2-targeted therapy
Presenter: Fatima Cardoso
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
HER new potential: New advances in HER2+ breast cancer treatment
Presenter: Erika Hamilton
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Sharing HER experience: Case-based panel discussion
Presenter: Erika Hamilton
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Closing remarks
Presenter: Eva Ciruelos
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Emerging research with immune checkpoint inhibitors in basal cell carcinoma (BCC)
Presenter: Susana Puig
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Welcome and Introduction
Presenter: Robert Coleman
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Evolution of diagnosis and classification of endometrial cancer and emergence of molecular classification
Presenter: Amit Oza
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Endometrial cancer as an attractive target for checkpoint inhibitor-based therapy
Presenter: Robert Coleman
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Monotherapy checkpoint inhibitor studies in recurrent endometrial cancer
Presenter: Renaud Sabatier
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast